NO923412D0 - Fremgangsmaate for enantiomeropploesning av 5-hetaryl-1,3,4-tiadiazinon - Google Patents

Fremgangsmaate for enantiomeropploesning av 5-hetaryl-1,3,4-tiadiazinon

Info

Publication number
NO923412D0
NO923412D0 NO923412A NO923412A NO923412D0 NO 923412 D0 NO923412 D0 NO 923412D0 NO 923412 A NO923412 A NO 923412A NO 923412 A NO923412 A NO 923412A NO 923412 D0 NO923412 D0 NO 923412D0
Authority
NO
Norway
Prior art keywords
resolution
thiadiazinon
hetaryl
procedure
diastereoisomers
Prior art date
Application number
NO923412A
Other languages
English (en)
Other versions
NO923412L (no
NO300498B1 (no
Inventor
Rochus Jonas
Peter Ersing
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO923412D0 publication Critical patent/NO923412D0/no
Publication of NO923412L publication Critical patent/NO923412L/no
Publication of NO300498B1 publication Critical patent/NO300498B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO923412A 1991-09-02 1992-09-01 Fremgangsmåte for enantiomeropplösning av 5-heteroaryl-1,3,4-tiadiazinon NO300498B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4129062A DE4129062A1 (de) 1991-09-02 1991-09-02 Verfahren zur enantiomerentrennung von 5-hetaryl-1,3,4-thiadiazinonen

Publications (3)

Publication Number Publication Date
NO923412D0 true NO923412D0 (no) 1992-09-01
NO923412L NO923412L (no) 1993-03-03
NO300498B1 NO300498B1 (no) 1997-06-09

Family

ID=6439631

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923412A NO300498B1 (no) 1991-09-02 1992-09-01 Fremgangsmåte for enantiomeropplösning av 5-heteroaryl-1,3,4-tiadiazinon

Country Status (20)

Country Link
US (1) US5206363A (no)
EP (1) EP0530657B1 (no)
JP (1) JPH05202041A (no)
KR (1) KR930006016A (no)
AT (1) ATE144982T1 (no)
AU (1) AU658215B2 (no)
CA (1) CA2077031A1 (no)
CZ (1) CZ281376B6 (no)
DE (2) DE4129062A1 (no)
DK (1) DK0530657T3 (no)
ES (1) ES2095992T3 (no)
GR (1) GR3022443T3 (no)
HU (1) HU212178B (no)
MX (1) MX9204972A (no)
NO (1) NO300498B1 (no)
PL (1) PL169606B1 (no)
RU (1) RU2053231C1 (no)
SK (1) SK278678B6 (no)
TW (1) TW234113B (no)
ZA (1) ZA926617B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19500558A1 (de) * 1995-01-11 1996-07-18 Merck Patent Gmbh 3-Alkoxycarbonyl-thiadiazinone
DE19707641C1 (de) * 1997-02-26 1998-03-26 Merck Patent Gmbh Enantiomerentrennung von 5-Hetaryl-1,3,4-thiadiazinonen
DE19929785A1 (de) * 1999-06-29 2001-01-04 Bayer Ag Tetrahydrochinolinyl-6-methyldihydrothiadiazinon-Derivate und ihre Verwendung
WO2001051089A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische zubereitungen enthaltend 2-pyrrolidon als lösungsvermittler
US7741317B2 (en) * 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77031A (en) * 1985-11-12 1995-12-08 Yeda Res & Dev Kinetic resolution of racemic mixtures by polymer-bound crystallization inhibitors
US4716246A (en) * 1986-08-22 1987-12-29 Merck & Co., Inc. Process for L-dopa
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones

Also Published As

Publication number Publication date
SK263492A3 (en) 1997-12-10
DE59207484D1 (de) 1996-12-12
NO923412L (no) 1993-03-03
NO300498B1 (no) 1997-06-09
DE4129062A1 (de) 1993-03-04
AU658215B2 (en) 1995-04-06
RU2053231C1 (ru) 1996-01-27
EP0530657B1 (de) 1996-11-06
PL295804A2 (en) 1993-03-08
US5206363A (en) 1993-04-27
HUT63414A (en) 1993-08-30
CZ263492A3 (en) 1993-03-17
CA2077031A1 (en) 1993-03-03
TW234113B (no) 1994-11-11
HU9202806D0 (en) 1992-11-30
AU2205192A (en) 1993-03-11
GR3022443T3 (en) 1997-04-30
EP0530657A1 (de) 1993-03-10
PL169606B1 (pl) 1996-08-30
MX9204972A (es) 1993-03-01
ATE144982T1 (de) 1996-11-15
CZ281376B6 (cs) 1996-09-11
JPH05202041A (ja) 1993-08-10
ES2095992T3 (es) 1997-03-01
DK0530657T3 (da) 1997-04-07
HU212178B (en) 1996-03-28
KR930006016A (ko) 1993-04-20
SK278678B6 (en) 1997-12-10
ZA926617B (en) 1993-03-25

Similar Documents

Publication Publication Date Title
JPS5535013A (en) New pt-complex
DE69023934T2 (de) Substanz PF 1022, Verfahren zu ihrer Herstellung und diese Substanz enthaltende anthelmintische Zusammensetzung.
ES8601100A1 (es) Un procedimiento para producir 3-(3, 4-dihidroxifenil) serina
KR910021368A (ko) 광학적으로 활성이 있는 아미노산 아마이드의 제조 방법
ATE125544T1 (de) Verfahren zur herstellung von amikacin.
NO923412L (no) Fremgangsmaate for enantiomeropploesning av 5-hetaryl-1,3,4-tiadiazinon.
ATE114637T1 (de) Verfahren zur herstellung von antikonvulsanten cyclischen aminosäureverbindungen.
DE69133494D1 (de) Microbiologische Herstellung von L-Ascorbinsäure
DE59201373D1 (de) Verfahren zur Herstellung von L-Carnitin aus D,L-Carnitinnitrilsalzen.
SE435499B (sv) Diastereomert salt av s-1-t-butylamino-2,3-dihydroxipropan
RU94045250A (ru) Способы получения 2-перфторалкил-3-оксазолин-5-она промежуточные соединения
ATE233267T1 (de) Verfahren zur herstellung von 3- vinylcephalosporinen
DE69803636T2 (de) Verfahren zur Herstellung von (1S,2R)-1-Amino-2-indanol-(R,R)-tartrate methanol Solvat
GR3002989T3 (en) Process for the production of n-acylated mercapto-alpha-amino acids
KR870007165A (ko) 퀴누클리딘 유도체의 제조방법
CA2197900A1 (en) Racemization of optically active amines
JPS5538363A (en) Preparation of optically active n-mercaptoacyl-imino acid
FI875602A (fi) Optiskt aktivt tetrahydro-2-furanonderivat saosom miksobicid.
KR940003937A (ko) 신규한 이소부틸-치환 메탄술포닐 퀴놀릴메톡시페닐-시클로알킬아세트아미드
ATE104940T1 (de) Trennung von 1,2-dihydroxycyclohexa-3,5-dienverbindungen.
GB1494725A (en) Resolution process
ATE92481T1 (de) Verfahren zur herstellung von n,n'-bis-(2hydroxyethyl)-piperazin.
KR910006227A (ko) 크로토노베타인히드로클로리드의 제조방법
ATE35679T1 (de) Verfahren zur herstellung von cis-3,3,5trimethylcyclohexyl-d,l-alpha-(3-pyridincarboxy - phenylacetat.
TH13050EX (th) สารประกอบทางเภสัช